Amdocs (DOX) Competitors $88.26 -0.98 (-1.10%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$88.28 +0.02 (+0.02%) As of 07/11/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DOX vs. CTSH, IT, LDOS, BAH, CACI, EPAM, TDC, HCKT, UIS, and FORRShould you be buying Amdocs stock or one of its competitors? The main competitors of Amdocs include Cognizant Technology Solutions (CTSH), Gartner (IT), Leidos (LDOS), Booz Allen Hamilton (BAH), CACI International (CACI), EPAM Systems (EPAM), Teradata (TDC), The Hackett Group (HCKT), Unisys (UIS), and Forrester Research (FORR). These companies are all part of the "it consulting & other services" industry. Amdocs vs. Its Competitors Cognizant Technology Solutions Gartner Leidos Booz Allen Hamilton CACI International EPAM Systems Teradata The Hackett Group Unisys Forrester Research Amdocs (NASDAQ:DOX) and Cognizant Technology Solutions (NASDAQ:CTSH) are both large-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations. Is DOX or CTSH more profitable? Cognizant Technology Solutions has a net margin of 11.73% compared to Amdocs' net margin of 11.39%. Amdocs' return on equity of 19.52% beat Cognizant Technology Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Amdocs11.39% 19.52% 10.85% Cognizant Technology Solutions 11.73%16.73%12.26% Do institutionals and insiders hold more shares of DOX or CTSH? 92.0% of Amdocs shares are held by institutional investors. Comparatively, 92.4% of Cognizant Technology Solutions shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.3% of Cognizant Technology Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer DOX or CTSH? Amdocs currently has a consensus target price of $105.33, suggesting a potential upside of 19.34%. Cognizant Technology Solutions has a consensus target price of $85.00, suggesting a potential upside of 12.79%. Given Amdocs' stronger consensus rating and higher possible upside, analysts plainly believe Amdocs is more favorable than Cognizant Technology Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amdocs 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Cognizant Technology Solutions 0 Sell rating(s) 14 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.22 Does the media favor DOX or CTSH? In the previous week, Cognizant Technology Solutions had 13 more articles in the media than Amdocs. MarketBeat recorded 24 mentions for Cognizant Technology Solutions and 11 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 1.09 beat Amdocs' score of 0.90 indicating that Cognizant Technology Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cognizant Technology Solutions 14 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, DOX or CTSH? Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmdocs$5.00B1.99$493.20M$4.7518.58Cognizant Technology Solutions$19.74B1.88$2.24B$4.7515.87 Is DOX or CTSH a better dividend stock? Amdocs pays an annual dividend of $2.11 per share and has a dividend yield of 2.4%. Cognizant Technology Solutions pays an annual dividend of $1.24 per share and has a dividend yield of 1.6%. Amdocs pays out 44.4% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 26.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years and Cognizant Technology Solutions has increased its dividend for 6 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has more risk and volatility, DOX or CTSH? Amdocs has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500. Comparatively, Cognizant Technology Solutions has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. SummaryCognizant Technology Solutions beats Amdocs on 9 of the 17 factors compared between the two stocks. Get Amdocs News Delivered to You Automatically Sign up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DOX vs. The Competition Export to ExcelMetricAmdocsIT Services IndustryComputer SectorNASDAQ ExchangeMarket Cap$10.07B$16.90B$27.76B$9.11BDividend Yield2.36%1.50%3.11%4.01%P/E Ratio18.5838.8836.8520.25Price / Sales1.9912.021,883.2599.65Price / Cash12.2125.1938.1558.16Price / Book2.964.877.275.49Net Income$493.20M$434.10M$767.31M$250.27M7 Day Performance-4.71%-5.91%-0.21%4.80%1 Month Performance-6.19%-2.19%4.08%7.68%1 Year Performance9.38%14.65%52,050.71%16.36% Amdocs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DOXAmdocs4.7921 of 5 stars$88.26-1.1%$105.33+19.3%+11.2%$10.07B$5.00B18.5829,058Analyst ForecastCTSHCognizant Technology Solutions4.8723 of 5 stars$78.49-1.8%$85.00+8.3%+7.4%$38.71B$20.09B16.53336,800Trending NewsITGartner4.6061 of 5 stars$393.53-0.2%$515.89+31.1%-16.4%$30.21B$6.30B24.4321,044Trending NewsLDOSLeidos4.5231 of 5 stars$162.39+0.1%$177.46+9.3%+8.8%$20.84B$16.66B16.2948,000Positive NewsBAHBooz Allen Hamilton4.967 of 5 stars$107.59+0.5%$134.64+25.1%-32.0%$13.30B$11.98B14.7735,800News CoverageCACICACI International2.3154 of 5 stars$487.19+0.4%$520.31+6.8%+10.8%$10.67B$8.36B22.8924,000Analyst ForecastEPAMEPAM Systems4.9385 of 5 stars$176.17-3.1%$233.93+32.8%-10.1%$9.96B$4.73B24.6061,200Positive NewsTDCTeradata4.2722 of 5 stars$22.39-1.5%$27.25+21.7%-37.5%$2.15B$1.75B15.815,700Positive NewsHCKTThe Hackett Group4.2413 of 5 stars$25.72-0.8%$31.33+21.8%+11.4%$710.72M$313.86M30.231,478UISUnisys4.5433 of 5 stars$4.31-1.3%$6.50+51.0%-9.7%$305.96M$2.01B-4.0215,900Analyst DowngradeFORRForrester Research4.0348 of 5 stars$10.17-0.1%N/A-43.7%$193.55M$432.47M-2.221,571 Related Companies and Tools Related Companies Cognizant Technology Solutions Competitors Gartner Competitors Leidos Competitors Booz Allen Hamilton Competitors CACI International Competitors EPAM Systems Competitors Teradata Competitors The Hackett Group Competitors Unisys Competitors Forrester Research Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DOX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amdocs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Amdocs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
